Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

September 30, 2019

Study Completion Date

December 30, 2019

Conditions
Hypoglycemia
Interventions
DRUG

Insulin

In each clamp, a small intravenous catheter is placed in participant's arm for infusion of insulin together with potassium phosphate and glucose. Insulin is a hormone that body makes naturally and it causes blood sugar to decrease. Insulin (and glucose) will be infused in calculated doses to maintain blood sugar level in the target range of 95 mg/dl or 50 mg/dl depending on the clamp.

DRUG

Glucose

Glucose is administered together with insulin and potassium phosphate during each clamp via the intravenous catheter. Glucose is a sugar and it is used to carefully regulate blood sugar level.

DRUG

Potassium phosphate

Potassium phosphate is administered together with glucose and insulin during each clamp via the intravenous catheter. Potassium is a salt-like substance that is present in the blood.

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT02866435 - Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes | Biotech Hunter | Biotech Hunter